Momelotinib Impurity 22 | CAS 945749-05-3 - Request Quote
Momelotinib Impurity 22
| SZ CAT No: | SZ-M168035 |
| CAS No | 945749-05-3 |
| Mol.F. | C21H21N5O2 |
| Mol.Wt. |
375.4 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Momelotinib Impurity 22 is chemically 4-(2-((4-morpholinophenyl)amino)pyrimidin-4-yl)benzamide. Momelotinib Impurity 22 is supplied with detailed characterization data compliant with regulatory guideline. Momelotinib Impurity 22 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Momelotinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 945749-05-3
Purchase 945749-05-3
Order 945749-05-3
Enquire 945749-05-3
price of 945749-05-3
945749-05-3 Supplier
945749-05-3 Manufacturer
945749-05-3 Exporter
buy high quality Momelotinib Impurity 22
Purchase Momelotinib Impurity 22
Momelotinib Impurity 22 suppliers
Momelotinib Impurity 22 manufacturers
Momelotinib Impurity 22 price
Order Momelotinib Impurity 22
Enquire Momelotinib Impurity 22
Momelotinib Impurity 22 cost
Momelotinib Impurity 22 Supplier
Momelotinib Impurity 22 Distributor
Momelotinib Impurity 22 for Method Validation
Momelotinib Reference Standard
Momelotinib Impurity 22 for ANDA Filing
Momelotinib Impurity 22 for Forced Degradation Studies
Momelotinib Impurity 22 Identification Standards
Momelotinib Impurity 22 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


